(CNBC) -- Stocks rose on Monday after AstraZeneca and the University of Oxford said their coronavirus vaccine was up to 90% effective, becoming the third inoculation this month that was revealed to be effective in trial data.
The Dow Jones Industrial Average closed 327.79 points higher, or 1.1%, at 29.591.27. The S&P 500 gained 0.6% to end the day at 3,577.59, and the Nasdaq Composite advanced 0.2% to 11,880.63.
AstraZeneca said interim analysis showed its vaccine has an average efficacy of 70% with one dosing regimen showing effectiveness of 90%, while the other demonstrating 62% efficacy. This follows late-stage trial data from Pfizer-BioNTech and Moderna showing that their respective Covid-19 vaccines were around 95% effective.
The post Dow jumps 300 points on vaccine hope appeared first on WND.
